FDA Investigator Gam S Zamil

Gam S Zamil has inspections in 12 countries as of 01 Nov 2023. Gam S Zamil has collaborated with a combinined 5358 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
90
Last Inspection Date:
01 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Italy, China, Bangladesh, Canada, India, Japan, Thailand, Singapore, Korea (Republic of), Mexico, Malaysia
Co-Investigator(s):
Ademola O Daramola, Alan L Truong, Alexandra B Pitkin, Alice S Tsao, Alicia M Mozzachio, Amatul H Marium, Ana Djurdjevic, Anastasia M Shields, Andrea A Branche, Andrew M Barlow, Angela E Glenn, Anita Narula, PhD, Ann L Demarco, Anna Lazar, Anna M Brannen, Anthony C Warchut, Anthony Kovalenko, Arduino Frankovic, Arie C Menachem, Armen H Youssoufian, Arsen Karapetyan, Bailey A Uetrecht, Bijoy Panicker, Bonita S Chester, Bowman, Brandy N Lepage, Bryan L Mcguckin, Burnell M Henry, Carla J Lundi, Carlos Chavez, Carolyn J Cook, Caryn M Mcnab, Cassandra L Abellard, CDR Ileana Barreto Pettit, Celena Ngo, Charanjeet Jassal, Charisse K Green, Charles D Brown, Charles I Ann, Charles M Edwards, Cheryl A Clausen, Christina A Miller, Christopher K Vantwuyver, Christopher M Hernandez, Christopher T Middendorf, Claire M Minden, Claudia Mperez Kasmarski, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Dana A Razzano, David H Hsu, David P Moorhead, David R Delucia, David Y Hernandez, Davis, Debra J Fracassa, Dell S Moller, Demitria J Argiiropoulos, Demitria J Argiropolous, Demitria J Argiropoulos, Demitria J Xiradakis, Dipesh K Shah, Djamila Harouaka, Donald G Gordon, Donald L Lech, Dr. Robert C Horan, MD, Edward D Mcdonald, Edwin Martinez, Elisa A Nickum, Elizabeth Ll Edwards, Emily J Orban, Erica B Raphael, Erik W Koester, Erika V Butler, Esteban Beltran, Farhana Khan, Feiyan Jin, Felix Maldonado, Frank Wackes, Freddy Ortiz Colon, Frederick M Lochner, Gabriel Guevarra, Gabriel M Guevarra, Gary J Hagan, Gary J Lehr, Gary T Greco, George J Flynn, Geraldine H Matining, Geraldine M Peregrin, Glen C Lawrence, Grace P Santos, Guerlain Ulysse, Gwyn G Dickinson, Heriberto Negron Rivera, Hugh M Mcclure, II, Ivan E Reyes, Jacqueline S Warner, James A Liubicich, James C Maclaughlin, James M Mason, James P Mcreavey, James S Cartwright, Jason F Chancey, Jay T Wong, Jazmine M Welcher, Jeff M Uriarte, Jeffrey P Raimondi, Jill J Tillman, Joan M Cantellops Figueroa, Joey V Quitania, Jogy George, John A Gonzalez, Johnna L Bleem, Jolanna A Norton, Jonathan W Chapman, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Jose O Hernandez, Jose R Hernandez, Josh Renzon Ramilo, Joshua P Wireman, Joshua Wireman, Joy P Matthias, Juan Rjimenez Garcia, Juanita P Versace, Judy C Nepsa, Julianne C Mccullough, Junho Pak, Justin A Boyd, Karen L Kosar, Karishma G Gopaul, Katherine E Jacobitz, Katherine Szestypalow, Kathleen D Culver, Kathryn A Nagy, Kelvin Cheung, Kelvin X Sanders, Kenneth G Klobus, Kevin A Gonzalez, Kevin P Foley, Kham Phommachanh, Kim Lthomas Cruse, Kimberley A Ricketts, Kwong P Lee, Lakecha N Lewis, Langer, Larry K Hampton, Lata C Mathew, PhD, Lauren N Howard, Laurie B Frazier, Lauryl A Smith, Lawrence W Farina, LCDR Chad N Thompson, Leo B Zadecky, Liatte Kreuger, PharmD, Lilly O Barton, Liming Zhang, Linda F Murphy, Linda Thai, Lindsey M Schwierjohann, Lisa M Bellows, Lisa Shin, Logan T Williams, Luis A Dasta, Lynnsey A Renn, Mancia R Walker, Marcus F Yambot, Margaret E Sarles, Maribeth G Grattan, Maribeth G Niesen, Marisa R Eschmann, Mark E Parmon, Marsha L Mccauley, Martin J Guardia, Mary Jeanet Mcgarry, Massoud Motamed, Matthew A Spataro, Matthew B Casale, Matthew J Sienko, Matthew R Clabeaux, Meredith P Soehl, Investigator, Michael A Charles, Michael D Garcia, Michael E Clark, Michael P Sheehan, Michael R Goga, Michael W Burd, Michele L Obert, Miguel A Martinez, Mihaly S Ligmond, Mindy M Chou, Mra Davism, Mra Mcculloughj, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Natasha Gupta, Nazmul Hassan, Nebil A Oumer, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas A Violand, Nicole E Knowlton, Parul M Patel, Patrick C Klotzbuecher, Patty P Kaewussdangkul, Paul E Stein, Paul L Bellamy, Paul Mouris, Peter Abel, Peter C Chow, Philip F Istafanos, DMV, MS, Pratik S Upadhyay, DDC, Qin Xu, Rachael O Oyewole, Rafeeq A Habeeb, Raihan A Chowdhury, Richard E Needham, Richard W Tubb, Robert C Hoover, Robert C Howard, Robert C Steyert, Robert D Ogan, Robert D Tollefsen, Robert J Doyle, Robert J Martin, Robert J Veitch, Rochelle A Rolnik, Ronald Ifraimov, Rose Xu, Roy C Stephens, Rozelle G Smith, Saied A Asbagh, Saleem A Akhtar, Samina S Khan, Samir C Gala, Sandersk, Sandra A Hughes, Sanket N Patel, Santiago Gallardo Johnson, Sarah A Hassas, Satheesh Thomas, Saundrea A Munroe, Sayyem H Akbar, Scott T Ballard, Sean P Desbrow, Simone E Pitts, Siobhan A Gallagher, Sixto M Mercado Rios, Sneha S Patel, Sony Mathews, Sonya M Edmonds, Srinivas R Chennamaneni, PhD, State Agency, Steven J Libal, Steven M Weinman, Steven P Donald, Susan M Joseph, Susan O Oladeji, Susanne M Richardson, MSc RAC ELS, Taichun Qin, PhD, Tamala P Magee, Tanya R Syffrard, Tara K Carmody, Tawny L Colling, Ted L Anderson, Teresa I Navas, Terri L Dodds, Terry Bridgewater, Thao T Kwan, Theresa Kirkham (NMI), Thomas J Arista, Thomas J Mooney, Timothy T Kapsala, Torrance J Slayton, Travis R Hunt, Truong Xuan Nguyen (Andy), Trushani T Desai, Tyanna N Hadley, Ucheabuchi C Chudi Nwankwor, Uduak M Inokon, Unnee Ranjan, Uttaniti Limchumroon (Tom), Vilmary Negron Rodriguez, Vincent Thomas, Virgilio F Pacio, CSO, Viviana Matta, Vivin George, Vlada Matusovsky, Walden H Lee, Wen Ning Chan (Sally), William M Rennells, Xiaokuang Lai, PhD, Xikui Chen (nmi), PhD, Yumi J Hiramine, Yvette Mlacour Davis, Zachary A Bogorad, Zhao Wang, PhD, Zhongren Wu

Gam S Zamil's Documents

Publish Date Document Type Title
August, 2019 FDA 483 Takeda Giken Service, Ltd. - Form 483, 2019-08-09
August, 2021 FDA 483 Advanced Pharmaceutical Technology, Inc. - Form 483, 2021-08-23
January, 2023 FDA 483 Keshava Organics Private Limited - Form 483, 2023-01-13
August, 2023 FDA 483 Sciarra Laboratories, Inc. - Form 483, 2023-08-07
March, 2016 FDA 483 Samson Pharmaceuticals, Inc. - Form 483, 2016-03-25
June, 2022 FDA 483 AARTI PHARMALABS LIMITED - Form 483, 2022-06-23
December, 2021 FDA 483 ScieGen Pharmaceuticals, INC. - Form 483, 2021-12-20
March, 2018 FDA 483 AmLion Toothpaste Mfg. Sdn. Bhd. - Form 483, 2018-03-02
May, 2018 EIR MSN Laboratories Private Limited - EIR, 2018-05-25
January, 2017 FDA 483 Alps Pharmaceutical Ind. Co., Ltd. - Form 483, 2017-01-27
January, 2023 FDA 483 Anicare Pharmaceuticals Pvt. Ltd. - Form 483, 2023-01-20
December, 2022 FDA 483 LNK International, Inc. - Form 483, 2022-12-13
November, 2017 EIR Curia New York, Inc. - EIR, 2017-11-09
August, 2022 FDA 483 RK PHARMA INC. - Form 483, 2022-08-12
October, 2022 FDA 483 Steri-Pharma, LLC - Form 483, 2022-10-04
May, 2019 EIR Maithri Laboratories Private Limited - EIR, 2019-05-31
October, 2020 FDA 483 Velocity Pharma LLC - Form 483, 2020-10-23
May, 2016 EIR Allergan Sales, LLC - EIR, 2016-05-20
September, 2015 FDA 483 GRAM Laboratories, Inc. - Form 483, 2015-09-04
April, 2022 FDA 483 SLV Pharmaceuticals LLC - Form 483, 2022-04-14
May, 2019 FDA 483 Cdymax (India) Pharma Private Limited - Form 483, 2019-05-17
September, 2019 FDA 483 Advanced Pharmaceutical Technology, Inc. - Form 483, 2019-09-27
May, 2019 FDA 483 SHODHANA LABORATORIES LIMITED - Form 483, 2019-05-23
April, 2023 FDA 483 ACI HealthCare Limited - Form 483, 2023-04-06
June, 2016 FDA 483 Corden Pharma Bergamo SpA - Form 483, 2016-06-17
June, 2018 FDA 483 Vasudha Pharma Chem Limited - Form 483, 2018-06-01
December, 2015 FDA 483 Paklab - Form 483, 2015-12-22
December, 2018 FDA 483 ZHEJIANG LEPU PHARMACEUTICAL CO., LTD. - Form 483, 2018-12-07
September, 2021 FDA 483 SSG Ventures - Form 483, 2021-09-30
April, 2017 FDA 483 Torrent Pharmaceuticals Limited - Form 483, 2017-04-28
February, 2022 FDA 483 IntelGenx Corp. - Form 483, 2022-02-25
July, 2022 FDA 483 Alkem Laboratories Limited - Form 483, 2022-07-07
November, 2023 FDA 483 Spirit Pharmaceuticals LLC - Form 483, 2023-11-01

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more